Cargando…

Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite

Detalles Bibliográficos
Autores principales: Honrao, Chandrashekhar, Ma, Xiaoyu, Kulkarni, Shashank, Joshi, Vinit, Malamas, Michael, Zvonok, Alexander, Wood, JodiAnne, Kautz, Roger A., Strand, David, Guo, Jason J., Makriyannis, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100890/
https://www.ncbi.nlm.nih.gov/pubmed/33967764
http://dx.doi.org/10.3389/fphar.2021.630274
_version_ 1783688875404689408
author Honrao, Chandrashekhar
Ma, Xiaoyu
Kulkarni, Shashank
Joshi, Vinit
Malamas, Michael
Zvonok, Alexander
Wood, JodiAnne
Kautz, Roger A.
Strand, David
Guo, Jason J.
Makriyannis, Alexandros
author_facet Honrao, Chandrashekhar
Ma, Xiaoyu
Kulkarni, Shashank
Joshi, Vinit
Malamas, Michael
Zvonok, Alexander
Wood, JodiAnne
Kautz, Roger A.
Strand, David
Guo, Jason J.
Makriyannis, Alexandros
author_sort Honrao, Chandrashekhar
collection PubMed
description
format Online
Article
Text
id pubmed-8100890
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81008902021-05-07 Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite Honrao, Chandrashekhar Ma, Xiaoyu Kulkarni, Shashank Joshi, Vinit Malamas, Michael Zvonok, Alexander Wood, JodiAnne Kautz, Roger A. Strand, David Guo, Jason J. Makriyannis, Alexandros Front Pharmacol Pharmacology Frontiers Media S.A. 2021-04-22 /pmc/articles/PMC8100890/ /pubmed/33967764 http://dx.doi.org/10.3389/fphar.2021.630274 Text en Copyright © 2021 Honrao, Ma, Kulkarni, Joshi, Malamas, Zvonok, Wood, Kautz, Strand, Guo and Makriyannis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Honrao, Chandrashekhar
Ma, Xiaoyu
Kulkarni, Shashank
Joshi, Vinit
Malamas, Michael
Zvonok, Alexander
Wood, JodiAnne
Kautz, Roger A.
Strand, David
Guo, Jason J.
Makriyannis, Alexandros
Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
title Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
title_full Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
title_fullStr Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
title_full_unstemmed Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
title_short Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
title_sort corrigendum: metabolic profiling of a cb2 agonist, am9338, using lc-ms and microcoil-nmr: identification of a novel dihydroxy adamantyl metabolite
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100890/
https://www.ncbi.nlm.nih.gov/pubmed/33967764
http://dx.doi.org/10.3389/fphar.2021.630274
work_keys_str_mv AT honraochandrashekhar corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT maxiaoyu corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT kulkarnishashank corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT joshivinit corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT malamasmichael corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT zvonokalexander corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT woodjodianne corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT kautzrogera corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT stranddavid corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT guojasonj corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite
AT makriyannisalexandros corrigendummetabolicprofilingofacb2agonistam9338usinglcmsandmicrocoilnmridentificationofanoveldihydroxyadamantylmetabolite